Home > Insider Trading > Filing (0001209191-17-027995)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1108205	Curis Inc	CRIS	Biological Products, (No Disgnostic Substances) (2836)	043505116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190126	R James Mcnab	4 Maguire Road Lexington MA 02421		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2017-04-20	22,541	$2.66	1,357,147	No	4	S	Direct
Common Stock	Disposition	2017-04-21	45,705	$2.58	1,311,442	No	4	S	Direct
Common Stock	Disposition	2017-04-24	42,076	$2.56	1,269,366	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $2.61 to $2.69, inclusive. The filer undertakes to provide to Curis Inc., any security holder of Curis, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.65, inclusive. The filer undertakes to provide to Curis Inc., any security holder of Curis, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.58, inclusive. The filer undertakes to provide to Curis Inc., any security holder of Curis, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.